UPLC-MS/MS assay for the simultaneous quantification of carvedilol and its active metabolite 4′-hydroxyphenyl carvedilol in human plasma to support a bioequivalence study in healthy volunteers-Reference-Cited by-同舟云学术

UPLC-MS/MS assay for the simultaneous quantification of carvedilol and its active metabolite 4′-hydroxyphenyl carvedilol in human plasma to support a bioequivalence study in healthy volunteers

Published:2013-03 Issue: Volume: Page:n/a-n/a
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomed. Chromatogr.

Author:

Patel Daxesh P.¹,Sharma Primal¹,Sanyal Mallika²,Singhal Puran³,Shrivastav Pranav S.¹

Affiliation:

1. Department of Chemistry, School of Sciences; Gujarat University; Ahmedabad; 380009; Gujarat; India

2. Department of Chemistry; St. Xavier's College; Navrangpura; Ahmedabad; 380009; Gujarat; India

3. Alkem Laboratories Ltd; MIDC Ind Estate, Taloja (MIDC); Navi Mumbai; Maharashtra; 410208; India

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference41 articles.

1. Determination of carvedilol in human cardiac tissue by high-performance liquid chromatography;Behn;Journal of Chromatographic Science,2001a

2. HPLC quantification of carvedilol in small plasma volumes from children;Behn;Chromatographia,2001b

3. Quantification of carvedilol in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to bioequivalence study;Borges;Journal of Chromatography B,2005

4. Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseases;Chakraborty;Expert Opinion on Drug Metabolism & Toxicology,2010

5. High-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of carvedilol and its metabolite 4′-hydroxyphenyl carvedilol in human plasma and its application to bioequivalence study;Chandiran;Journal of Chemical and Pharmaceutical Research,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel synchronous fluorescence approach for the simultaneous determination of tafamidis and carvedilol in human plasma at nanogram levels: Compliance with greenness metrics;Microchemical Journal;2024-10

2. DEVELOPMENT AND VALIDATION OF AN LC-MS/MS METHOD FOR THE DETERMINATION OF TENOFOVIR AND EMTRICITABINE;International Journal of Applied Pharmaceutics;2024-03-07

3. A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4^/-hydroxyphenyl carvedilol at a low dose;Research in Pharmaceutical Sciences;2022

4. Low‐volume LC–MS/MS method for the pharmacokinetic investigation of carvedilol, enalapril and their metabolites in whole blood and plasma: Application to a paediatric clinical trial;Drug Testing and Analysis;2020-11-22

5. Novel Trends in Analytical Methods for β-Blockers: An Overview of Applications in the Last Decade;Critical Reviews in Analytical Chemistry;2020-07-19